Abstract:Study question: Is circulating heme oxygenase-1 (HO-1) associated with the risk of polycystic ovary syndrome (PCOS)? Summary answer: Lower circulating HO-1 is associated with a higher risk of PCOS in non-obese women, in a dose-related manner. What is known already: PCOS is one of the most common endocrine disorders in women of reproductive age, with increasing worldwide incidence. HO-1 plays a crucial role in many physiological systems, with potent anti-inflammatory, antioxidant and antimetabolic properties. Study design, size, duration: This hospital-based case-control study included 80 women with PCOS and 80 healthy control women seen at the Reproductive Center of Tongji Hospital (Wuhan, China) from November 2011 to May 2012. Cases and controls were frequency-matched on age and BMI and were enrolled into the study once written informed consent had been obtained. Participants/materials, setting, methods: Serum hormones, glucose, insulin and lipid concentrations were measured using an automated platform. Correlation coefficients and multiple linear regression models were calculated in the combined group (both cases and controls) using serum HO-1 concentration as the independent variable and age and BMI as covariate variables to explore the association between HO-1 and the pathophysiology of PCOS. To examine the independent association of serum HO-1 levels with the likelihood of PCOS, multivariate logistic analysis was used. The strength of the association was tested further by receiver-operating characteristic (ROC) curve models, with or without the addition of HO-1. Main results and the role of chance: Compared with controls, women with PCOS were found to have significantly increased insulin resistance (IR), oxidative stress (OS) and inflammation levels, creating a vicious circle of effects in the pathophysiology of PCOS. However, serum HO-1 was negatively associated with this vicious circle. Women with the highest tertile of HO-1 (≥5.29 ng/ml) had an odds ratio (OR) of PCOS of 0.02 (95% CI 0.0034-0.07) compared with women with the lowest quartile (<3.14 ng/ml) (P < 0.01). This trend remained after adjustment for potential confounders in the multivariable model (all P < 0.01). ROC analysis based on an existing prognostic model yielded significantly discriminative values for PCOS, with or without the addition of HO-1 (areas under the curves were 0.86 (95% CI 0.81-0.92) versus 0.95 (95% CI 0.92-0.98); P for difference = 0.0005). Limitations, reasons for caution: It is difficult to establish a time-integrated measure of circulating HO-1 during the progression of PCOS and these findings should be confirmed in large-scale studies involving different ethnic groups. Moreover, the study lacks measurements of glycated hemoglobin (HbA1c) to provide an index of blood glucose concentrations over time. Wider implications of the findings: Circulating HO-1 that provides protection against IR, OS and chronic inflammation is markedly reduced in non-obese women with PCOS. Low serum HO-1 is suggested as an independent risk factor for PCOS; thus, circulating HO-1 levels may be a novel biomarker for PCOS in young, non-obese women. Study funding/competing interest(s): This work was supported by grants from the National Natural Science Foundation of China (81202210) and the National Science and Technology Support Program of China (2012BAI02B02). None of the authors has any conflict of interest to declare.

Alteration of sialoglycoprotein in the glomerular basement membrane of diabetic glomerulosclerosis.

Increased oxidative stress is associated with hyperandrogenemia in polycystic ovary syndrome evidenced by oxidized lipoproteins stimulating rat ovarian androgen synthesis in vitro

Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

A Molecular Mechanism Underlying Ovarian Dysfunction of Polycystic Ovary Syndrome: Hyperandrogenism Induces Epigenetic Alterations in the Granulosa Cells

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome

Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome

Oxidative stress in polycystic ovary syndrome: a case- control study

[The effects of oxidative stress to PCOS]

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women

Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women

Efficacy of Antioxidant Supplementation in Improving Endocrine, Hormonal, Inflammatory, and Metabolic Statuses of PCOS: A Meta-analysis and Systematic Review

Obesity is Associated with SHBG Levels Rather Than Blood Lipid Profiles in PCOS Patients with Insulin Resistance

Role of Oxidative Stress in Obese and Nonobese PCOS Patients

Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?

Suppression of P66shc Prevents Hyperandrogenism-Induced Ovarian Oxidative Stress and Fibrosis

Heme oxygenase 2 genetic variants alter hormonal and metabolic traits in polycystic ovary syndrome

Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives